(Q37623115)

21 August 2017

1 reference

title

Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease (English)

1 reference

21 August 2017

1 reference

William C Cromwell

1

1 reference

21 August 2017

Thomas A Barringer

series ordinal

2

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Current cardiology reports

21 August 2017

published in

1 reference

21 August 2017

volume

11

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

468-475

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-009-0067-z

21 August 2017

exact match

0 references

cites work

Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11886-009-0067-Z

Apolipoprotein concentrations during treatment and recurrent coronary artery disease events

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11886-009-0067-Z

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

21 January 2018

1 reference

12 December 2020

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management

1 reference

12 December 2020

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial

1 reference

12 December 2020

Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

1 reference

12 December 2020

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

1 reference

12 December 2020

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

12 December 2020

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes

1 reference

12 December 2020

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

1 reference

12 December 2020

Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation

1 reference

12 December 2020

Metabolic origins and clinical significance of LDL heterogeneity

1 reference

12 December 2020

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

1 reference

12 December 2020

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

1 reference

12 December 2020

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

1 reference

12 December 2020

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update

1 reference

12 December 2020

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

12 December 2020

Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia

1 reference

12 December 2020

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Comparison of the relationships between serum apolipoprotein B and serum lipid distributions

1 reference

12 December 2020

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

1 reference

12 December 2020

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

12 December 2020

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

1 reference

12 December 2020

Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl

1 reference

12 December 2020

Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women

1 reference

12 December 2020

Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice

1 reference

12 December 2020

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

1 reference

12 December 2020

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

1 reference

12 December 2020

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis

1 reference

12 December 2020

Measurement issues related to lipoprotein heterogeneity

1 reference

12 December 2020

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

1 reference

12 December 2020

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

1 reference

12 December 2020

Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.

1 reference

12 December 2020

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

12 December 2020

Effect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels

1 reference

12 December 2020

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

1 reference

12 December 2020

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance

1 reference

12 December 2020

Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study

1 reference

12 December 2020

Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study

1 reference

12 December 2020

High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol.

1 reference

12 December 2020

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

12 December 2020

Risk factors for acute myocardial infarction in the elderly (the Dubbo study).

1 reference

12 December 2020

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study

1 reference

12 December 2020

10.1007/S11886-009-0067-Z

Identifiers

DOI

1 reference

21 August 2017

1 reference